Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients of non-small cell lung cancer and its comparison with PERCIST response criteria

被引:0
作者
Dang, Shreya [1 ]
Shivdasani, Divya [1 ]
Pereira, Melvika [1 ]
Singh, Natasha [1 ]
Rungta, Rachita [1 ]
Roy, Debdip [1 ]
Kesariya, Jugal [1 ]
机构
[1] PD Hinduja Natl Hosp & Med Res Ctr, Dept Nucl Med & PET CT, Veer Savarkar Marg, Mumbai 400016, India
关键词
evaluation; FDG PET; Hopkins; NSCLC; PERCIST; response; POSITRON-EMISSION-TOMOGRAPHY;
D O I
10.1097/MNM.0000000000001756
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim To assess treatment response on FDG PET-CT in NSCLC patients by visual Hopkins score compared to PERCIST criteria and its potential for prognostication (or its correlation with survival).Methods Forty-four NSCLC patients with baseline and post-treatment FDG PET-CT scans were included, and interpreted using Hopkins and PERCIST criteria classifying patients into responders and non-responders. PERCIST-based CMR and PMR, and Hopkins Scores 1,2,3 were classified responders. PERCIST-based SD and PD and Hopkins scores 4,5 were classified as non-responders. Patients were followed upto 24 months after treatment completion. Cohen kappa for inter-criteria agreement and Kaplan Meir curve for overall survival (OS) analysis done.Results Out of 44 patients, PERCIST classified 27 (61.3%) as responders and 17 (38.6%) as non-responders, whereas Hopkins classified 12 patients (27.3%) as responders and 32 (72.7%) as non-responders. Inter-criteria agreement was low (kappa=0.19) with discordance in 45.5% of patients. Eighteen of 20 discordant cases were non-responders on Hopkins and responders on PERCIST, of which 88.8% were non-responders on follow-up as predicted by Hopkins. PERCIST responders had OS of 96.4% and 64.3% at 9 and 24 months, respectively, while non-responders OS was 93.5% and 40.2% at 9 and 24 months, respectively (P-value = 0.049). However, responders on Hopkins had OS of 100% at 24 months, whereas non-responders had OS of 93.5% and 51.5% at 9 and 24 months, respectively (P-value = 0.232).Conclusion Semi-quantitative PERCIST and visual Hopkins criteria show low inter-criteria agreement, with visual criteria better-predicting survival in patients of NSCLC.
引用
收藏
页码:1038 / 1045
页数:8
相关论文
共 10 条
  • [1] Revalidation of PET/computed tomography criteria (Hopkins criteria) for the assessment of therapeutic response in lung cancer patients: inter-reader reliability, accuracy and survival outcomes
    Al Riyami, Khulood
    Al Nuaimi, Noor
    Kliokyte, Ruta
    Voo, Stefan
    Thornton, Andrew
    Bomanji, Jamshed
    Fraioli, Francesco
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (01) : 18 - 25
  • [2] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
  • [3] Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
    Ferlay, J.
    Colombet, M.
    Soerjomataram, I.
    Mathers, C.
    Parkin, D. M.
    Pineros, M.
    Znaor, A.
    Bray, F.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1941 - 1953
  • [4] Recent advances in the management of lung cancer
    Jones, Gavin S.
    Baldwin, David R.
    [J]. CLINICAL MEDICINE, 2018, 18 (02) : S41 - S46
  • [5] Molecular Biology of Lung Cancer: Clinical Implications
    Larsen, Jill E.
    Minna, John D.
    [J]. CLINICS IN CHEST MEDICINE, 2011, 32 (04) : 703 - +
  • [6] 18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
    Sheikhbahaei, Sara
    Mena, Esther
    Marcus, Charles
    Wray, Rick
    Taghipour, Mehdi
    Subramaniam, Rathan M.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 855 - 860
  • [7] What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?
    Turgeon, Guy-Anne
    Iravani, Amir
    Akhurst, Tim
    Beaulieu, Alexis
    Callahan, Jason W.
    Bressel, Mathias
    Cole, Aidan J.
    Everitt, Sarah J.
    Siva, Shankar
    Hicks, Rodney J.
    Ball, David L.
    Mac Manus, Michael P.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) : 328 - 334
  • [8] 18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
    Usmanij, Edwin A.
    de Geus-Oei, Lioe-Fee
    Troost, Esther G. C.
    Peters-Bax, Liesbeth
    van der Heijden, Erik H. F. M.
    Kaanders, Johannes H. A. M.
    Oyen, Wim J. G.
    Schuurbiers, Olga C. J.
    Bussink, Johan
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (09) : 1528 - 1534
  • [9] Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review
    Vansteenkiste, J
    Fischer, BM
    Dooms, C
    Mortensen, J
    [J]. LANCET ONCOLOGY, 2004, 5 (09) : 531 - 540
  • [10] Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography:: Review and 1999 EORTC recommendations
    Young, H
    Baum, R
    Cremerius, U
    Herholz, K
    Hoekstra, O
    Lammertsma, AA
    Pruim, J
    Price, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (13) : 1773 - 1782